BAXTYMA Trademark

Trademark Overview


On Thursday, September 26, 2024, a trademark application was filed for BAXTYMA with the United States Patent and Trademark Office. The USPTO has given the BAXTYMA trademark a serial number of 98770787. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, September 26, 2024. This trademark is owned by AstraZeneca Ireland Limited. The BAXTYMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances
baxtyma

General Information


Serial Number98770787
Word MarkBAXTYMA
Filing DateThursday, September 26, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, September 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 26, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAstraZeneca Ireland Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDublin 15 D15R925
IE

Trademark Events


Event DateEvent Description
Thursday, September 26, 2024NEW APPLICATION ENTERED
Thursday, September 26, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED